Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedFeb 16, 2026
DataAggregated Company Financials
Companies227
  • 7D-1.5%
  • 3M10.1%
  • 1Y0.8%
  • YTD6.7%

Over the last 7 days, the Healthcare industry has dropped 2.1%, driven by Caliway Biopharmaceuticals declining 6.4%. Meanwhile, Heron Neutron Medical actually outperformed within the industry, gaining 6.9% in the last week. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 59% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 16 Feb 2026NT$1.8tNT$269.0bNT$11.5b19x157.3x6.7x
Wed, 14 Jan 2026NT$1.7tNT$268.8bNT$13.4b19x126.3x6.3x
Fri, 12 Dec 2025NT$1.7tNT$267.4bNT$13.6b18.8x127.6x6.5x
Sun, 09 Nov 2025NT$1.7tNT$268.5bNT$8.7b21x191.1x6.2x
Tue, 07 Oct 2025NT$1.8tNT$266.0bNT$8.2b22x218.9x6.8x
Thu, 04 Sep 2025NT$1.9tNT$266.1bNT$8.7b22.2x217.9x7.1x
Sat, 02 Aug 2025NT$1.6tNT$262.2bNT$15.0b20.7x106.9x6.1x
Mon, 30 Jun 2025NT$1.7tNT$260.9bNT$16.4b19.6x101x6.3x
Wed, 28 May 2025NT$1.5tNT$260.7bNT$16.3b19.7x92.2x5.8x
Fri, 25 Apr 2025NT$1.4tNT$254.7bNT$12.1b19.6x112.1x5.3x
Sun, 23 Mar 2025NT$1.6tNT$254.1bNT$11.8b21.9x137.7x6.4x
Tue, 18 Feb 2025NT$1.7tNT$246.5bNT$8.4b23.9x200.7x6.9x
Thu, 16 Jan 2025NT$1.5tNT$245.2bNT$8.6b21.9x177.5x6.2x
Sat, 14 Dec 2024NT$1.5tNT$245.0bNT$8.6b21.9x169.4x6x
Mon, 11 Nov 2024NT$1.5tNT$238.3bNT$7.8b22.6x196.8x6.4x
Wed, 09 Oct 2024NT$1.6tNT$236.4bNT$6.8b24.9x230.6x6.6x
Fri, 06 Sep 2024NT$1.6tNT$236.4bNT$6.8b25.1x231.6x6.6x
Sun, 04 Aug 2024NT$1.6tNT$229.1bNT$3.5b27.9x452.2x6.9x
Tue, 02 Jul 2024NT$1.7tNT$228.6bNT$3.9b29.2x433.9x7.4x
Thu, 30 May 2024NT$1.5tNT$228.6bNT$3.9b26x380.6x6.5x
Sat, 27 Apr 2024NT$1.4tNT$228.8bNT$4.2b25.9x336.7x6.2x
Mon, 25 Mar 2024NT$1.4tNT$228.8bNT$7.5b25.4x191x6.3x
Wed, 21 Feb 2024NT$1.4tNT$225.8bNT$6.5b25.6x220.2x6.3x
Fri, 19 Jan 2024NT$1.4tNT$224.9bNT$6.0b24.6x230.9x6.2x
Sun, 17 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.4x241.2x6.3x
Tue, 14 Nov 2023NT$1.4tNT$225.2bNT$7.7b25.2x178.4x6.1x
Thu, 12 Oct 2023NT$1.4tNT$225.3bNT$8.3b25.1x164.2x6x
Sat, 09 Sep 2023NT$1.4tNT$225.2bNT$8.4b25.5x163.3x6.1x
Mon, 07 Aug 2023NT$1.4tNT$226.8bNT$11.3b24.8x124.4x6.2x
Wed, 05 Jul 2023NT$1.5tNT$226.5bNT$11.6b26.1x125.7x6.4x
Fri, 02 Jun 2023NT$1.4tNT$226.1bNT$13.7b23.3x104.2x6.3x
Sun, 30 Apr 2023NT$1.4tNT$220.1bNT$12.1b23.2x119.4x6.6x
Tue, 28 Mar 2023NT$1.4tNT$219.8bNT$12.4b21.5x115x6.5x
Thu, 23 Feb 2023NT$1.4tNT$214.5bNT$13.6b21.5x105.1x6.7x
Price to Earnings Ratio

105.1x


Total Market Cap: NT$1.4tTotal Earnings: NT$13.6bTotal Revenue: NT$214.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 190.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 157x which is lower than its 3-year average PE of 190x.
  • The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 5.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market3.95%
Healthcare-1.48%
Medical Equipment1.61%
Life Sciences0.31%
Healthcare Services-0.31%
Biotech-0.47%
Pharma-3.48%
Healthtech-3.64%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 21.4x.
    • Analysts are expecting annual earnings decline of 13.5%, which is less than its past year's earnings decline of 28.5%.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 88% over the next 5 years.
  • This is better than its past earnings growth rate of 3.8% per year.
  • In contrast, the Healthtech industry is expected to see its earnings decline by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7799 Heron Neutron MedicalNT$473.506.9%
+NT$4.8b		50.3%PS13408.8x
7871 Elixiron Immunotherapeutics (Cayman)NT$63.1025.2%
+NT$1.7b		n/aPS8258.2x
6785 Alar PharmaceuticalsNT$267.504.7%
+NT$801.6m		71.5%PS14261x
4123 Center LaboratoriesNT$40.002.4%
+NT$709.2m		2.5%PE16.8x
6550 Polaris GroupNT$29.902.6%
+NT$577.9m		-40.4%PS325.2x

Latest News

6576
NT$84.60
Foresee Pharmaceuticals
7D
-3.1%
1Y
-2.0%
6472
NT$490.00
Bora Pharmaceuticals
7D
-12.2%
1Y
-34.1%

6472: Corealis Alliance Will Support Future Upside Through End To End Development

Analysts have modestly adjusted their price target on Bora Pharmaceuticals to reflect updated assumptions around discount rate, revenue growth, profit margin and future P/E. This has resulted in a refreshed fair value estimate of about NT$741.02 per share.
1795
NT$292.50
Lotus Pharmaceutical
7D
-12.4%
1Y
4.7%
6446
NT$725.00
PharmaEssentia
7D
-0.8%
1Y
4.4%
1789
NT$21.65
ScinoPharm Taiwan
7D
-5.5%
1Y
-5.3%
6696
NT$397.00
Lin BioScience
7D
-3.1%
1Y
178.6%
6949
NT$678.00
Pell Bio-Med Technology
7D
-1.0%
1Y
419.5%
6550
NT$29.90
Polaris Group
7D
2.6%
1Y
-40.4%
4104
NT$77.70
Excelsior Medical
7D
2.1%
1Y
-5.6%
6785
NT$267.50
Alar Pharmaceuticals
7D
4.7%
1Y
71.5%
6919
NT$160.00
Caliway Biopharmaceuticals
7D
-1.8%
1Y
74.5%
7799
NT$473.50
Heron Neutron Medical
7D
6.9%
1Y
50.3%
6589
NT$61.20
EirGenix
7D
2.2%
1Y
-25.2%
4123
NT$40.00
Center Laboratories
7D
2.4%
1Y
2.5%
6499
NT$95.00
Medeon Biodesign
7D
2.6%
1Y
131.4%